MedPath

Effect of subsequence treatment after romosozumab in patietns with osteoporosis: open-label, randomised contorlled trial

Not Applicable
Conditions
Osteoporosis
Registration Number
JPRN-UMIN000040132
Lead Sponsor
Department of Orthopaedic Surgery, Showa University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
105
Inclusion Criteria

Not provided

Exclusion Criteria

1.Those who have history of cancer. 2.Patients with severe renal dysfunction or those receiving dialysis 3. Those who have hypocalcemia 4.Patients who is going to have an operation. 5.Patients who the research director judge inappropriate as a subject 6.For pregnant women or women who are nursing 7. Nonambulatory patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath